DE69629846D1 - Substituierte arylalkylamine als neurokinin-antagonisten - Google Patents

Substituierte arylalkylamine als neurokinin-antagonisten

Info

Publication number
DE69629846D1
DE69629846D1 DE69629846T DE69629846T DE69629846D1 DE 69629846 D1 DE69629846 D1 DE 69629846D1 DE 69629846 T DE69629846 T DE 69629846T DE 69629846 T DE69629846 T DE 69629846T DE 69629846 D1 DE69629846 D1 DE 69629846D1
Authority
DE
Germany
Prior art keywords
alkyl
heteroaryl
nr6r7
aryl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69629846T
Other languages
English (en)
Other versions
DE69629846T2 (de
Inventor
A Reichard
G Aslanian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DE69629846D1 publication Critical patent/DE69629846D1/de
Application granted granted Critical
Publication of DE69629846T2 publication Critical patent/DE69629846T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DE69629846T 1996-10-28 1996-10-28 Substituierte arylalkylamine als neurokinin-antagonisten Expired - Fee Related DE69629846T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/016822 WO1998018761A1 (en) 1996-10-28 1996-10-28 Substituted arylalkylamines as neurokinin antagonists

Publications (2)

Publication Number Publication Date
DE69629846D1 true DE69629846D1 (de) 2003-10-09
DE69629846T2 DE69629846T2 (de) 2004-07-08

Family

ID=22255993

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69629846T Expired - Fee Related DE69629846T2 (de) 1996-10-28 1996-10-28 Substituierte arylalkylamine als neurokinin-antagonisten

Country Status (12)

Country Link
EP (1) EP0934271B1 (de)
JP (1) JP2001507673A (de)
KR (1) KR20000052856A (de)
AT (1) ATE248818T1 (de)
AU (1) AU7460796A (de)
CA (1) CA2268866C (de)
DE (1) DE69629846T2 (de)
ES (1) ES2202481T3 (de)
HU (1) HUP9903653A3 (de)
IL (1) IL129430A0 (de)
NZ (1) NZ334966A (de)
WO (1) WO1998018761A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29137A (id) * 1998-07-27 2001-08-02 Schering Corp Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1
TW200303304A (en) 2002-02-18 2003-09-01 Astrazeneca Ab Chemical compounds
AU2003275257A1 (en) 2002-09-26 2004-04-19 Bristol-Myers Squibb Company N-substituted heterocyclic amines as modulators of chemokine receptor activity
US7494987B2 (en) 2002-11-25 2009-02-24 Mochida Pharmaceutical Co., Ltd. Agent for treating respiratory diseases containing 4-hydroxypiperidine derivative as active ingredient
TW200524868A (en) 2003-07-31 2005-08-01 Zeria Pharm Co Ltd Benzylamine derivatives
SE0400208D0 (sv) 2004-02-02 2004-02-02 Astrazeneca Ab Chemical compounds
EP2129381A1 (de) 2007-01-24 2009-12-09 Glaxo Group Limited Pharmazeutische zubereitungen enthaltend 3,5-diamino-6-(2,3-dichlophenyl)-1,2,4-triazin or r(-)-2,4-diamino-5-(2,3dichlorophenyl)-6-fluoromethyl pyrimidin und einen nk1- rezeptor-antagonisten

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical preparations containing them
JPH08511522A (ja) * 1993-06-07 1996-12-03 メルク エンド カンパニー インコーポレーテッド ニューロキニンアンタゴニストとしてのスピロ置換アザ環

Also Published As

Publication number Publication date
KR20000052856A (ko) 2000-08-25
WO1998018761A1 (en) 1998-05-07
HUP9903653A2 (hu) 2000-03-28
CA2268866C (en) 2005-12-06
ES2202481T3 (es) 2004-04-01
ATE248818T1 (de) 2003-09-15
JP2001507673A (ja) 2001-06-12
HUP9903653A3 (en) 2001-05-28
CA2268866A1 (en) 1998-05-07
NZ334966A (en) 2000-10-27
EP0934271B1 (de) 2003-09-03
AU7460796A (en) 1998-05-22
IL129430A0 (en) 2000-02-17
EP0934271A1 (de) 1999-08-11
DE69629846T2 (de) 2004-07-08

Similar Documents

Publication Publication Date Title
NL300132I1 (nl) Hydroxy-gesubstitueerde azetidinonverbindingen, bruikbaar als hypocholesterolemische middelen.
YU35697A (en) Substituted 6,6-hetero-bicyclic derivatives
YU34896A (sh) Supstituisani n-(indol-2-karbonil)-glicinamidi, njihovi intermedijeri i farmaceutske kompozicije
FI980175A (fi) 2-sulfonamidofenonijohdannaisia
ATE91684T1 (de) 1,2-cyclohexylaminoarylamide zu verwendung als analgetika.
NO302818B1 (no) Sulfonamidokarboksamider, anvendelse derav for fremstilling av farmasöytiske preparater og mellomprodukter for fremstilling av förstnevnte
DE69629846D1 (de) Substituierte arylalkylamine als neurokinin-antagonisten
PT733621E (pt) Novos derivados de imidazole e processo para a sua preparacao
CA2045359A1 (en) 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines
BG102959A (en) Benzooxazinon antagonists of domamine d4 receptor
HUP9902091A2 (hu) Benzodioxán-metil-amin indol-alkil-származékok és alkalmazásuk 5-HT1A receptor ligandumként
YU71496A (en) Azetidines, their salts, application and process for preparation
NO953052L (no) Nye pyrrolokarbazoler
DE69208604D1 (de) Imidazol-Verbindungen, ihre Herstellung und Verwendung als Calcium-Kanal Blocker
ES2152379T3 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos.
EP0757988A4 (de) Imidazolderivat und ein verfahren zu seiner herstellung
NO933837L (no) 4-aryl-3-(heteroarylureido)kinolin-derivater
CO4340626A1 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos
ATE188470T1 (de) Chinolondisulfide als zwischenverbindungen
DE69701770D1 (de) Enolether und ihre Verwendung als Fungizide
YU126791A (sh) Supstituisani piroli
MX9804482A (es) Quinolinas y quinazolinas utiles en terapias.
MX9701944A (es) Nuevos derivados de 2-(3h)-oxazolona.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee